Prevention of Ventricular Dysfunction With Enalapril and Carvedilol in Patients Submitted to Intensive Chemotherapy for the Treatment of Malignant Hemopathies.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Carvedilol; Enalapril
- Indications Left ventricular dysfunction
- Focus Biomarker; Pharmacogenomic; Therapeutic Use
- Acronyms OVERCOME
Most Recent Events
- 15 Nov 2013 Biomarkers information updated
- 29 Aug 2012 Results presented at the ESC Congress 2012: Annual Congress of the European Society of Cardiology.
- 01 May 2012 Status changed from active, no longer recruiting to completed.